Oxford Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Oxford Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,549	Closed	-$349K	–	1758
2018 Q3	$349K	Sell	4,549 -8,375	-65%	-$674K	0.01%	1454
2018 Q2	$1.09M	Buy	+12,924	New	+$1.13M	0.02%	994
2017 Q2	–	Sell	-13,814	Closed	-$807K	–	1449
2017 Q1	$807K	Sell	13,814 -26,462	-66%	-$1.27M	0.02%	887
2016 Q4	$1.68M	Buy	40,276 +18,973	+89%	+$996K	0.06%	373
2016 Q3	$1.13M	Buy	+21,303	New	+$928K	0.03%	499

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Oxford Asset Management's AGIO Position: Q4 2018 in Review

Oxford Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q4 2018, closing a stake of 4,549 shares — an estimated $349K sold.

Oxford Asset Management first reported a position in AGIO in Q3 2016 and held it in 5 quarters. The position peaked at $1.68M in Q4 2016. 196 funds tracked by Wall St. Rank hold AGIO as of Q4 2018.

Oxford Asset Management reported no remaining Agios Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Oxford Asset Management sold 4,549 Agios Pharmaceuticals shares in Q4 2018, an estimated $349K.
Oxford Asset Management first reported a position in Agios Pharmaceuticals in Q3 2016 and held it in 5 quarters.
Oxford Asset Management's Agios Pharmaceuticals position peaked at $1.68M in Q4 2016.
196 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2018.

Based on Oxford Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.